Skip to main content
OpenTrials
Completed

NCT Number: NCT02486237

Complications in Central American Diabetic Patients: Historic Cohort

Retrospective, observational study to determine the prevalence of complications in Central American diabetic patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital CIMA, San José, Provincia de San José, Costa Rica

Loading trial locations.

About this study

This is retrospective observational study aimed to determine the prevalence of complications in Central American diabetic patients. Patients included are treated in the usual outpatient practice setting and we will try to determine the prevalence of diabetic complications in these patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • type 2 diabetes mellitus diagnosed between 2004 and 2009
  • seen by the attending physician for the first time between January and December 2009.
  • male or female patients between 18 and 80 years

Exclusion criteria

  • none

Treatment and study plan

none, observational study

Other

None, it is an observational study

Primary outcomes

  1. Number of patients with microvascular and cardiovascular complications

    Time frame: up to 10 years

Secondary outcomes

  1. Number of participants with at least one episode of hypoglycemia

    Time frame: up to 10 years

  2. Number of patients with microvascular and cardiovascular complications stratified by their glucose control

    Time frame: up to 10 years

  3. Number of patients with microvascular and cardiovascular complications stratified by blood pressure control

    Time frame: up to 10 years

  4. Number of patients with microvascular and cardiovascular complications stratified by cholesterol levels

    Time frame: up to 10 years

  5. Number of patients with microvascular and cardiovascular complications stratified by diabetes pharmacologic treatment

    Time frame: up to 10 years

Sponsors and collaborators

Lead sponsor

Clínica Los Yoses

Other

Collaborators

  • Novo Nordisk A/S

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jul 1, 2015
Registry last updated
Jul 27, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.